网站首页期刊介绍通知公告编 委 会投稿须知电子期刊广告合作联系我们
最新消息:
2型糖尿病是弥漫性特发性骨肥厚的潜在危险因素:两样本孟德尔随机化分析
作者:吴岳  郑剑卿  郭淳亮  房修乐  张钦  丁涛 
单位:南京医科大学附属无锡人民医院 骨科, 江苏 无锡 214000
关键词:弥漫性特发性骨肥厚 2型糖尿病 孟德尔随机化 因果关联 
分类号:R681; R587.1
出版年·卷·期(页码):2024·52·第七期(1031-1037)
摘要:

目的:探讨2型糖尿病(T2DM)是否会增加弥漫性特发性骨肥厚(DISH)的患病风险。方法:采用两样本孟德尔随机化(MR)分析方法评估T2DM与DISH的因果关系。从已发表的全基因组关联研究(GWAS)数据集中选取与T2DM(观察组61 714例,对照组593 952例)强相关的单核苷酸多态性(SNP)作为工具变量,以DISH(33 413例)作为结局进行分析。MR分析方法包括逆方差加权法(IVW)、MR-Egger回归法、加权中位数法、简单中位数法和加权众数法。采用Cochran's Q检验、漏斗图、MR-Egger、留一法及MR-PRESSO法进行敏感性检测并纠正偏倚值,保证结果的可靠性。结果:T2DM与DISH存在正向的因果关联,T2DM患者发生DISH的风险约为正常人的1.03倍(IVW:OR =1.030,95%CI 1.004~1.057,P=0.026)。MR-Egger检验显示,结果不存在多效性(P=0.126)。虽然初步分析结果经Cochran's Q检验显示存在异质性(P<0.001),但经MR-PRESSO法纠正偏倚值后,异质性消失(P=0.111)。重复分析结果无明显差异(IVW:OR=1.027,95%CI 1.004~1.052,P=0.024),且不存在水平多效性(P=0.09),留一法逐一删除SNP后分析结果无变化,结果可靠。结论:T2DM可能会增加DISH的患病风险,对于老年T2DM患者影像学检查发现存在椎体前外侧缘钙化或骨化者应警惕其罹患DISH的可能。

参考文献:

[1] FORESTIER J,ROTES-QUEROL J.Senile ankylosing hyperostosis of the spine[J].Ann Rheum Dis,1950,9(4):321-330.
[2] KUPERUS J S,MOHAMED HOESEIN F A A,DE JONG P A,et al.Diffuse idiopathic skeletal hyperostosis:etiology and clinical relevance[J].Best Pract Res Clin Rheumatol,2020,34(3):101527.
[3] KOBAYASHI K,OKADA E,YOSHII T,et al.Risk factors for delayed diagnosis of spinal fracture associated with diffuse idiopathic skeletal hyperostosis:a nationwide multiinstitution survey[J].J Orthop Sci,2021,26(6):968-973.
[4] OKADA E,YOSHII T,YAMADA T,et al.Spinal fractures in patients with diffuse idiopathic skeletal hyperostosis:a nationwide multi-institution survey[J].J Orthop Sci,2019,24(4):601-606.
[5] VIERUNEN R M,HAAPAMäKI V V,KOIVIKKO M P,et al.Post-traumatic spinal hematoma in diffuse idiopathic skeletal hyperostosis(DISH)[J].Eur Radiol,2023,33(12):9425-9433.
[6] SAWAKAMI K,WATANABE K,SATO T,et al.Rib hyperostosis as a risk factor for poor prognosis in cervical spine injury patients with diffuse idiopathic skeletal hyperostosis[J].Spine(Phila Pa 1976),2020,45(5):300-308.
[7] O'NEILL K R,NEUMAN B,PETERS C,et al.Risk factors for postoperative retropharyngeal hematoma after anterior cervical spine surgery[J].Spine(Phila Pa 1976),2014,39(4):E246-E252.
[8] LE H V,WICK J B,VAN B W,et al.Diffuse idiopathic skeletal hyperostosis of the spine:pathophysiology,diagnosis,and management[J].J Am Acad Orthop Surg,2021,29(24):1044-1051.
[9] OUDKERK S F,MOHAMED HOESEIN F A A,PTHM MALI W,et al.Subjects with diffuse idiopathic skeletal hyperostosis have an increased burden of coronary artery disease:an evaluation in the COPDGene cohort[J].Atherosclerosis,2019,287:24-29.
[10] AHMED O,RAMACHANDRAN K,PATEL Y,et al.Diffuse idiopathic skeletal hyperostosis prevalence,characteristics,and associated comorbidities:a cross-sectional study of 1815 whole spine CT scans[J].Global Spine J,2024,14(4):1201-1209.
[11] CHATTERJEE S,KHUNTI K,DAVIES M J.Type 2 diabetes[J].Lancet,2017,389(10085):2239-2251.
[12] ZERVOS T M,JAGO S S,ERWOOD M S,et al.A multicenter allelic analysis of diffuse idiopathic skeletal hyperostosis:nature versus nurture?[J].Neurosurgery,2023,93(2):348-357.
[13] AUðUNSSON A B,ELíASSON G J,STEINGRÍMSSON E,et al.Diffuse idiopathic skeletal hyperostosis in elderly Icelanders and its association with the metabolic syndrome:the AGES-Reykjavik study[J].Scand J Rheumatol,2021,50(4):314-318.
[14] MADER R,NOVOFASTOVSKI I,SCHWARTZ N,et al.Serum adiponectin levels in patients with diffuse idiopathic skeletal hyperostosis(DISH)[J].Clin Rheumatol,2018,37(10):2839-2845.
[15] HARLIANTO N I,OOSTERHOF N,FOPPEN W,et al.Diffuse idiopathic skeletal hyperostosis is associated with incident stroke in patients with increased cardiovascular risk[J].Rheumatology(Oxford),2022,61(7):2867-2874.
[16] YAMAMOTO T,OKADA E,MICHIKAWA T,et al.The impact of diabetes mellitus on spinal fracture with diffuse idiopathic skeletal hyperostosis:a multicenter retrospective study[J].J Orthop Sci,2022,27(3):582-587.
[17] 施桢宇,李人亮,胡子毅.基于孟德尔随机化方法探析衰弱与膝关节骨关节炎的因果关联[J].现代医学,2023,51(10):1398-1402.
[18] XUE A,WU Y,ZHU Z,et al.Genome-wide association analyses identify 143 risk variants and putative regulatory mechanisms for type 2 diabetes[J].Nat Commun,2018,9(1):2941.
[19] SETHI A,RUBY J G,VERAS M A,et al.Genetics implicates overactive osteogenesis in the development of diffuse idiopathic skeletal hyperostosis[J].Nat Commun,2023,14(1):2644.
[20] STAIGER D,STOCK J H.Instrumental variables regression with weak instruments[J].Econometrica,1997,65(3):557-586.
[21] YOSHIHARA H,NADARAJAH V,HOROWITZ E.Prevalence and characteristics of thoracic diffuse idiopathic skeletal hyperostosis in 3 299 black patients[J].Sci Rep,2021,11(1):22181.
[22] TOYODA H,TERAI H,YAMADA K,et al.Prevalence of diffuse idiopathic skeletal hyperostosis in patients with spinal disorders[J].Asian Spine J,2017,11(1):63-70.
[23] LI S,BANNO T,HASEGAWA T,et al.Long-term effects of diffuse idiopathic skeletal hyperostosis on physical function:a longitudinal analysis[J].J Orthop Sci,2024,29(1):109-114.
[24] ZHANG B,CHEN G,CHEN X,et al.Impact of diffuse idiopathic skeletal hyperostosis on clinico-radiological profiles and prognosis for thoracic ossification of ligamentum flavum-myelopathy:a propensity-matched monocentric analysis[J].Diagnostics(Basel),2022,12(7):1652.
[25] FASSIO A,ADAMI G,IDOLAZZI L,et al.Diffuse idiopathic skeletal hyperostosis(DISH) in type 2 diabetes:a new imaging possibility and a new biomarker[J].Calcif Tissue Int,2021,108(2):231-239.
[26] DELGADO-CALLE J,SATO A Y,BELLIDO T.Role and mechanism of action of sclerostin in bone[J].Bone,2017,96:29-37.
[27] NAPOLI N,CHANDRAN M,PIERROZ D D,et al.Mechanisms of diabetes mellitus-induced bone fragility[J].Nat Rev Endocrinol,2017,13(4):208-219.
[28] NIU C C,LIN S S,YUAN L J,et al.Correlation of blood bone turnover biomarkers and Wnt signaling antagonists with AS,DISH,OPLL,and OYL[J].BMC Musculoskelet Disord,2017,18(1):61.
[29] LICINI C,FARINELLI L,CERQUENI G,et al.Heterotopic ossification in a patient with diffuse idiopathic skeletal hyperostosis:input from histological findings[J].Eur J Histochem,2020,64(4):3176.
[30] LEE J H,LEE J H,RANE S G.TGF-β signaling in pancreatic islet β cell development and function[J].Endocrinology,2021,162(3):bqaa233.
[31] TSUKAMOTO S,KURATANI M,KATAGIRI T.Functional characterization of a unique mutant of ALK2,p.K400E,that is associated with a skeletal disorder,diffuse idiopathic skeletal hyperostosis[J].Bone,2020,137:115410.
[32] HIRASAWA A,ROBINSON Y,OLERUD C,et al.Regional differences in diffuse idiopathic skeletal hyperostosis:a retrospective cohort study from Sweden and Japan[J].Spine(Phila Pa 1976),2018,43(24):E1474-E1478.

服务与反馈:
文章下载】【发表评论】【查看评论】【加入收藏
提示:您还未登录,请登录!点此登录
您是第 822432 位访问者


 ©《现代医学》编辑部
联系电话:025-83272481;83272479
电子邮件: xdyx@pub.seu.edu.cn

本系统由北京博渊星辰网络科技有限公司设计开发 技术支持电话:010-63361626

苏ICP备09058541